Campylobacter infection is an abnormality observed in the digestive system caused by campylobacter bacteria. The most common sources of campylobacter infection are unpasteurized milk, raw poultry, or uncooked vegetables. Major symptoms of campylobacter infection include diarrhea, blood and mucus in stool, malaise, severe abdominal pain, nausea, fever, vomiting, and headache. On average, campylobacter infection lasts from two to 10 days. Campylobacter infection is diagnosed through laboratory tests of stool, body fluids, or tissue. Two types of tests are commonly performed: rapid test (analyzes the genetic material of campylobacter bacteria) and culture test (isolation of bacteria). Majorly, people affected with campylobacter infection are treated with antibiotics.

The global campylobacter diagnostics market is driven by several factors such as rise in population, sense of hygiene, diagnosis rate, cost of campylobacter infection diagnostic test, health care expenditure scenario, and presence of key market players. A study published in the Journal of Clinical Microbiology in 2016 revealed that the isolation and identification of the campylobacter infection from stool sample is the most challenging part in the campylobacter diagnosis test. Therefore, this market is likely to face challenges from sequencing of genetic materials of campylobacter infection, and un-automated data analysis during campylobacter detection method. R&D investments and technological advancements are likely to boost the growth of the global campylobacter diagnosis market during the forecast period.

Culture-based detection method is used to isolate and detect campylobacter infection from the sample. This method is cost-effective and requires no sophisticated instrument; however, it is time-consuming and has low-sensitivity. Rapid detection tests such as immunological or molecular techniques offer accurate result of campylobacter bacteria, although those tests are expensive as compared to culture based detection. Based on diagnosis method, the global campylobacter diagnosis market can be segmented into culture based diagnosis and rapid detection tests. Furthermore, the rapid detection tests can be segmented into immunological, molecular, and other methods. In terms of end-user, the market can be classified into hospitals, private laboratories, independent physician chambers, and others.

Geographically, the global campylobacter diagnostics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to the Centers for Disease Control and Prevention, an estimated 1.3 million people were affected with campylobacter infection in the U.S. in 2016. Nearly 200,000 confirmed cases were reported in Europe in 2014, with crude notification rate of 59.8 cases per 100,000 (reflecting an increase of 13% of the campylobacter notification rate in 2014 as compared to 2013). Significant infection rate, high diagnosis rate of campylobacter infection, well-established health care infrastructure, availability of medical reimbursement, and strong presence of key companies are likely to boost the growth of North America and Europe campylobacter diagnostics market in future. Several studies indicate that a significant number of people are affected by campylobacter infection in Asia Pacific. Around 5% to 15% of the total gastrointestinal cases in India and China in 2016 were campylobacter affected cases due to low sense of hygiene and poor sanitary system. The picture is quite shocking in Australia and New Zealand. Around 112.3 to 150.0 cases per 100,000 per year were affected in Australia and New Zealand in 2016. High number of campylobacter infected cases, developing medical infrastructure, high investment, and presence of key companies in Asia Pacific drive the campylobacter diagnostics market. Low awareness about campylobacter infection diagnosis and unfavorable medical reimbursements are the factors attributed to sluggish growth of the market in Latin America and Middle East & Africa.

Key players in the global campylobacter diagnostics market include Becton, Dickinson and Company, Meridian Bioscience, Inc., Thermo Fisher Scientific, BIOTECON Diagnostics, Agilent Technologies, Alere, QIAGEN, Roche Molecular Systems, Inc., Siemens Healthineers, Lonza, ZeptoMetrix, and Sequenom.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Campylobacter Diagnostics Market

Pre Book